AI opportunities in GU Cancers
November 12, 2022Read moreLooking to the future, Prof. Arnulf Stenzl (DE), Prof. Alberto Briganti (IT) and Dr. Bob Schijvenaars (NL) chaired the...
00
New trial results for PEACE-1, OpeRa, and adjuvant therapies in high-risk RCC
November 12, 2022Read moreA selection of new trial results were shared and discussed in Plenary Session 5 on day three of EMUC22....
Plenary Session 3 report: New strategies in BCa
November 11, 2022Read moreAfter a day full of supplementary meetings like ESUI22 and the YAU’s Autumn Meeting, day two of EMUC22 saw...
Diagnosing PCa – what’s the best option?
November 11, 2022Read moreThe objective of the 14th European Multidisciplinary Congress on Urological Cancers is to work together to achieve the best...
What’s new in GU Pathology and WHO classification?
November 10, 2022Read moreThe Uropathology Symposium (ESUP) delivered the latest updates on the WHO classification of genito-urinary tract tumours for 2022, and...
ESUI22: Examining the near future of imaging
November 10, 2022Read moreThe 10th Meeting of the EAU Section of Urological Imaging got off to a good start on Thursday, 10 November,...
The parallels to mountaineering are everywhere, even in urology
September 27, 2022Read moreVital updates on major trials, emerging technologies, and pioneering techniques will be featured during the 14th European Multidisciplinary Congress...
Protect yourself: Fake EMUC22 websites and scam emails
September 8, 2022Read morePlanning to attend EMUC22? Protect yourself against registration and hotel booking scams. Here’s how: Register via EMUC22’s official website...
EMUC22 Preview: “Treatment intensification in mHSPC is a hot topic right now”
September 5, 2022Read moreThe 14th European Multidisciplinary Congress on Urological Cancers (EMUC22) is coming to Budapest, Hungary, from the 10 to 13 November...
